137 related articles for article (PubMed ID: 7515211)
1. Management of hormone resistant prostate cancer.
Fosså SD
Acta Urol Belg; 1994 Apr; 62(1):73-6. PubMed ID: 7515211
[TBL] [Abstract][Full Text] [Related]
2. Results of strontium-89 therapy in patients with prostate cancer resistant to chemotherapy.
Gunawardana DH; Lichtenstein M; Better N; Rosenthal M
Clin Nucl Med; 2004 Feb; 29(2):81-5. PubMed ID: 14734902
[TBL] [Abstract][Full Text] [Related]
3. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
[TBL] [Abstract][Full Text] [Related]
4. [Metastatic prostate cancer].
Droz JP; Flechon A; Terret C
Rev Prat; 2003 Dec; 53(20):2258-62. PubMed ID: 15018080
[TBL] [Abstract][Full Text] [Related]
5. Innovative approaches to the hormonal treatment of advanced prostate cancer.
Trachtenberg J
Eur Urol; 1997; 32 Suppl 3():78-80. PubMed ID: 9267790
[TBL] [Abstract][Full Text] [Related]
6. Treatment options in androgen-independent prostate cancer.
Lara PN; Meyers FJ
Cancer Invest; 1999; 17(2):137-44. PubMed ID: 10071598
[TBL] [Abstract][Full Text] [Related]
7. Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial.
Sciuto R; Festa A; Rea S; Pasqualoni R; Bergomi S; Petrilli G; Maini CL
J Nucl Med; 2002 Jan; 43(1):79-86. PubMed ID: 11801708
[TBL] [Abstract][Full Text] [Related]
8. Quality of life in advanced prostate cancer.
Fosså SD
Semin Oncol; 1996 Dec; 23(6 Suppl 14):32-4. PubMed ID: 8996583
[TBL] [Abstract][Full Text] [Related]
9. Management of hormone refractory prostate cancer: current standards and future prospects.
Oh WK; Kantoff PW
J Urol; 1998 Oct; 160(4):1220-9. PubMed ID: 9751323
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant therapy prior to radiotherapy for clinically localized prostate cancer.
Roach M
Eur Urol; 1997; 32 Suppl 3():48-54. PubMed ID: 9267785
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness of repeated systematic radiotherapy for generalized prostate cancer].
Kiselev EN; Korytova LI; Karelin MI
Vopr Onkol; 2005; 51(6):689-91. PubMed ID: 17037036
[TBL] [Abstract][Full Text] [Related]
12. [Combined treatment for pain from bone metastases in patients with prostate cancer].
Ren X; Ying J; Yao D; Ye C; Jiang Y
Zhonghua Nan Ke Xue; 2004 Mar; 10(3):188-90. PubMed ID: 15080063
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of advanced prostate cancer].
Leisinger HJ; Jichlinski P
Rev Med Suisse Romande; 1999 Jun; 119(6):507-11. PubMed ID: 10422478
[No Abstract] [Full Text] [Related]
14. Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study.
Siddiqui SA; Boorjian SA; Inman B; Bagniewski S; Bergstralh EJ; Blute ML
J Urol; 2008 May; 179(5):1830-7; discussion 1837. PubMed ID: 18353378
[TBL] [Abstract][Full Text] [Related]
15. Bone pain palliation with 85Sr therapy.
Giammarile F; Mognetti T; Blondet C; Desuzinges C; Chauvot P
J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
[TBL] [Abstract][Full Text] [Related]
16. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
17. Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy.
Tu SM; Kim J; Pagliaro LC; Vakar-Lopez F; Wong FC; Wen S; General R; Podoloff DA; Lin SH; Logothetis CJ
J Clin Oncol; 2005 Nov; 23(31):7904-10. PubMed ID: 16258090
[TBL] [Abstract][Full Text] [Related]
18. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
19. Bone-targeted therapy: phase II study of strontium-89 in combination with alternating weekly chemohormonal therapies for patients with advanced androgen-independent prostate cancer.
Amato RJ; Hernandez-McClain J; Henary H
Am J Clin Oncol; 2008 Dec; 31(6):532-8. PubMed ID: 19060583
[TBL] [Abstract][Full Text] [Related]
20. The systemic treatment of bone metastases.
Houston SJ; Rubens RD
Clin Orthop Relat Res; 1995 Mar; (312):95-104. PubMed ID: 7543393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
